Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in ALNYLAM PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 280,965 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $93M as of 2026-Q1. The position was decreased (-27.9% shares). ALNY represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$93M
Current Shares
280,965
Total Value Change
+$62.3M
Total Shares Change
+154,953
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 280,965 |
-27.9% |
| $93M |
| 0.0% |
| $318.65 |
0 |
| 2025-Q4 | Increased | 389,435 | +154.5% | $154.9M | 0.1% | $397.25 | 49 |
| 2025-Q3 | Increased | 153,039 | +19.0% | $69.8M | 0.0% | $447.49 | 35 |
| 2025-Q2 | Increased | 128,634 | +202.1% | $41.9M | 0.0% | $322.83 | 47 |
| 2025-Q1 | Increased | 42,575 | +2.0% | $11.5M | 0.0% | $268.46 | 28 |
| 2024-Q4 | Decreased | 41,718 | -63.7% | $9.8M | 0.0% | $236.01 | 0 |
| 2024-Q3 | Decreased | 114,784 | -8.9% | $31.6M | 0.0% | $274.91 | 0 |
| 2024-Q2 | Increased | 126,012 | +24.2% | $30.6M | 0.0% | $243.00 | 35 |